Dr. Anne Bryden, PhD, OTR/L
Claim this profileClinical Trials Anne Bryden, PhD, OTR/L is currently running
More about Anne Bryden, PhD, OTR/L
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Anne Bryden, PhD, OTR/L has experience with
- Networked Neuroprosthesis Device
Breakdown of trials Anne Bryden, PhD, OTR/L has run
Spinal Cord Injury
Quadriplegia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anne Bryden, PhD, OTR/L specialize in?
Anne Bryden, PhD, OTR/L focuses on Spinal Cord Injury and Quadriplegia. In particular, much of their work with Spinal Cord Injury has involved treating patients, or patients who are undergoing treatment.
Is Anne Bryden, PhD, OTR/L currently recruiting for clinical trials?
Yes, Anne Bryden, PhD, OTR/L is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Anne Bryden, PhD, OTR/L has studied deeply?
Yes, Anne Bryden, PhD, OTR/L has studied treatments such as Networked Neuroprosthesis Device.
What is the best way to schedule an appointment with Anne Bryden, PhD, OTR/L?
Apply for one of the trials that Anne Bryden, PhD, OTR/L is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.